Download PDF
TumorDiagnostik & Therapie 2023; 44(07): 494-500
DOI: 10.1055/a-2133-1160
Thieme Onkologie aktuell

Intravaskuläre Therapieverfahren zu lokoregionalen Therapien von Lungentumoren

Intravascular Treatment Techniques for Locoregional Therapies of Lung Tumors
Thomas J. Vogl
1   Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany
,
Ahmed Mekkawy
1   Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany
,
Duaa B. Thabet
2   Department of Chest Diseases, Assiut University, Assiut, Egypt
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Hintergrund Die Inzidenz von Lungenkarzinomen hat im letzten Jahrhundert stark zugenommen. Darüber hinaus ist die Lunge der häufigste Ort der Metastasierung. Trotz der verbesserten Diagnostik und Therapie von Lungenmalignomen ist die Prognose der Patienten noch immer unbefriedigend. Lokoregionäre chemotherapeutische Techniken zur Behandlung von Lungenmalignomen haben heutzutage die Aufmerksamkeit der Forschung auf sich gezogen. Ziel dieses Übersichtsartikels ist es, verschiedene lokoregionale intravaskuläre Techniken und deren Behandlungsprinzipien vorzustellen und die jeweiligen Vor- und Nachteile als palliative und neoadjuvante Behandlungsmethode bei der Behandlung von Lungenmalignomen zu evaluieren.

Methode Die verschiedenen Verfahren bei der Behandlung von Lungenmalignomen wie isolierte Lungenperfusion (ILP), selektive pulmonale Arterienperfusion (SPAP), transpulmonale Chemoembolisation (TPCE), Bronchialarterieninfusion (BAI), Bronchialarterienchemoembolisation (BACE) und intraarterielle Chemoperfusion (IACP) werden vergleichend bewertet.

Ergebnisse Lokoregionale intravaskuläre Chemotherapieverfahren erweisen sich als vielversprechende Behandlungsoptionen bei der Behandlung von malignen Lungentumoren. Um optimale Ergebnisse zu erreichen, sollte mittels lokoregionaler Technik eine möglichst hohe Aufnahme des Chemotherapeutikums in das Zielgewebe mit schneller systemischer Clearance erzielt werden.

Schlussfolgerung Unter den verschiedenen Behandlungsoptionen bei Lungenmalignomen ist die TPCE das am besten evaluierte Behandlungskonzept. Allerdings sind weitere Studien nötig, um das optimale Behandlungskonzept mit den besten klinischen Ergebnissen zu definieren.

Kernaussagen 

  • Es existieren verschiedene Verfahren für die intravaskuläre Chemotherapie zur Behandlung von Lungenmalignomen.

  • Die transpulmonale Chemoembolisation (TPCE) ist derzeit das am besten evaluierte Therapieverfahren bei Lungenmalignomen.

  • Die Thermoablation nach neoadjuvanter Chemoperfusion stellt ein vielversprechendes Therapieverfahren bei Lungenmalignomen dar.

Zitierweise

  • Vogl TJ, Mekkawy A, Thabet DB. Intravascular Treatment Techniques for Locoregional Therapies of Lung Tumors. Fortschr Röntgenstr 2023; 195: 579–585

Abstract

Background Lung cancer incidence has greatly increased over the past century. Moreover, the lung is the most common site of metastatic involvement. Despite improvements in the diagnosis and treatment of lung malignancies, patient prognosis is still unsatisfactory. Locoregional chemotherapeutic techniques for the treatment of lung malignancies are the current focus of research. The aim of this review article is to present different locoregional intravascular techniques and their treatment principles and to assess the pros and cons of each of them as a palliative and neoadjuvant treatment method in the treatment of lung malignancy.

Method The different methods for the treatment of malignant lung lesions such as isolated lung perfusion (ILP), selective pulmonary artery perfusion (SPAP), transpulmonary chemoembolization (TPCE), bronchial artery infusion (BAI), bronchioarterial chemoembolization (BACE), and intraarteriel chemoperfusion (IACP) are evaluated comparatively.

Results Locoregional intravascular chemotherapy procedures are proving to be promising treatment options in the management of malignant lung tumors. In order to achieve optimal results, the locoregional technique should be used to achieve the highest possible uptake of the chemotherapeutic agent into the target tissue with rapid systemic clearance.

Conclusion Among the various treatment options for lung malignancies, TPCE is the best evaluated treatment concept. However, further studies are necessary to define the optimal treatment concept with the best clinical outcomes.

Key words

chemoembolization - interventional procedures - pulmonary metastases - lung cancer - locoregional techniques


Publication History

Article published online:
29 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Duma N, Santana-Davila R, Molina JR. Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc 2019; 94 (08) 1623-1640 DOI: 10.1016/j.mayocp.2019.01.013.
    CrossrefPubMedGoogle Scholar
  • 2 Rau B, Roth C, Schnider A. et al. Chirurgie der Lungenmetastasen extrapulmonaler Primärtumoren. Schweiz Med Forum 2002; 49: 1166-1170
    PubMedGoogle Scholar
  • 3 Branscheid D, Krysa S, Stoelben E. et al. Chirurgische Therapie von Lungenmetastasen beim Nierenzellkarzinom – Diagnostik, Strategie, Ergebnisse. Akt Urol 1992; 23: 107-112
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 David EA, Andersen SW, Beckett LA. et al. Survival benefits associated with surgery for advanced non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2019; 157 (04) 1620-1628
    CrossrefPubMedGoogle Scholar
  • 5 Lemjabbar-Alaoui H, Hassan OU, Yang Y-W. et al. Lung cancer: Biology and treatment options. Biochim Biophys Acta 2015; 1856: 189-210 DOI: 10.1016/j.bbcan.2015.08.002.
    CrossrefPubMedGoogle Scholar
  • 6 Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nature Reviews Cancer 2006; 6: 583-592 DOI: 10.1038/nrc1893.
    CrossrefPubMedGoogle Scholar
  • 7 Mentzer SJ, Antman KH, Attinger C. et al. Selected benefits of thoracotomy and chemotherapy for sarcoma metastatic to the lung. Journal of Surgical Oncology 1993; 53: 54-59
    CrossrefPubMedGoogle Scholar
  • 8 Genestreti G, Grossi F, Genova C. et al. Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview. Future Oncology 2014; 10: 2081-2096 DOI: 10.2217/fon.14.96.
    CrossrefPubMedGoogle Scholar
  • 9 Ren K, Wang J, Li Y. et al. The Efficacy of Drug-eluting Bead Transarterial Chemoembolization Loaded With Oxaliplatin for the Treatment of Stage III-IV Non-small-cell Lung Cancer. Acad Radiol 2022; 14 S1076-6332(22)00065-4 DOI: 10.1016/j.acra.2022.01.015a.
    CrossrefPubMedGoogle Scholar
  • 10 Vogl TJ, Shafinaderi M, Zangos S. et al. Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors. Semin Interven Radiol 2013; 30: 176-184
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Boas FE, Kemeny NE, Sofocleous CT. et al. Bronchial or Pulmonary Artery Chemoembolization for Unresectable and Unablatable Lung Metastases: A Phase I Clinical Trial. Radiology 2021; 301 (02) 474-484 DOI: 10.1148/radiol.2021210213.
    CrossrefPubMedGoogle Scholar
  • 12 Vogl TJ, Nour-Eldin NA, Albrecht MH. et al. Thermal Ablation of Lung Tumors: Focus on Microwave Ablation. Fortschr Röntgenstr 2017; 189 (09) 828-843 DOI: 10.1055/s-0043-109010.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 van Putte BP, Hendriks JM, Romijn S. et al. Isolated lung perfusion for the treatment of pulmonary metastases current mini-review of work in progress. Surgical Oncology 2003; 12: 187-193
    CrossrefPubMedGoogle Scholar
  • 14 Burt ME, Liu D, Abolhoda A. et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg 2000; 69: 1542-1549
    CrossrefPubMedGoogle Scholar
  • 15 Urano M. Invited Review: For the clinical application of thermo-chemotherapy given at mild temperatures. International Journal of Hyperthermia 1999; 15: 79-107 DOI: 10.1080/026567399285765.
    CrossrefPubMedGoogle Scholar
  • 16 Muller H, Hilger R. Curative and palliative aspects of regional chemotherapy in combination with surgery. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2003; 11: 1-10 DOI: 10.1007/s00520-002-0355-2.
    CrossrefPubMedGoogle Scholar
  • 17 van Putte BP, Hendriks JM, Romijn S. et al. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann Thorac Surg 2002; 74: 893-898
    CrossrefPubMedGoogle Scholar
  • 18 Demmy TL, Wagner-Mann C, Allen A. Isolated lung chemotherapeutic infusions for treatment of pulmonary metastases: a pilot study. Journal of Biomedical Science 2002; 9: 334-338
    CrossrefPubMedGoogle Scholar
  • 19 Mallick R, Demmy T. Regional lung chemotherapy techniques. Innovations 2011; 6: 1-9 DOI: 10.1097/IMI.0b013e31820b1e63.
    CrossrefPubMedGoogle Scholar
  • 20 van Putte BP, Grootenboers M, van Boven WJ. et al. Selective pulmonary artery perfusion for the treatment of primary lung cancer: Improved drug exposure of the lung. Lung Cancer 2009; 65: 208-213 DOI: 10.1016/j.lungcan.2008.11.004.
    CrossrefPubMedGoogle Scholar
  • 21 Den HengstWA, Hendriks JMH, Van Hoof T. et al. Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model†. European Journal of Cardio-Thoracic Surgery 2012; 42: 341-347 DOI: 10.1093/ejcts/ezs017.
    CrossrefPubMedGoogle Scholar
  • 22 Weksler B, Ng B, Lenert JT. et al. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg 1993; 56: 209-214
    CrossrefPubMedGoogle Scholar
  • 23 Lindemayr S, Lehnert T, Korkusuz H. et al. Transpulmonary chemoembolization: a novel approach for the treatment of unresectable lung tumors. Techniques in Vascular and Interventional Radiology 2007; 10: 114-119 DOI: 10.1053/j.tvir.2007.09.010.
    CrossrefPubMedGoogle Scholar
  • 24 Huppert PE, Geißler F, Duda SH. et al. Chemoembolisation des hepatozellulären Karzinoms: Computertomographische Befunde und klinische Resultate bei prospektiv repetitiver Therapie. Fortschr Röntgenstr 1994; 160: 425-432 DOI: 10.1055/s-2008-1032453.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Vogl TJ, Mekkawy AIA, Thabet DB. et al. Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases. European Radiology 2019; 29: 1939-1949 DOI: 10.1007/s00330-018-5757-8.
    CrossrefPubMedGoogle Scholar
  • 26 Schneider P, Kampfer S, Loddenkemper C. et al. Chemoembolization of the lung improves tumor control in a rat model. Clin Cancer Res 2002; 8: 2463-2468
    PubMedGoogle Scholar
  • 27 Golder WA. Chemoembolisation der Lunge. Der Onkologe 2008; 14: 934-939 DOI: 10.1007/s00761-008-1467-1.
    CrossrefPubMedGoogle Scholar
  • 28 Nguyen-Kim TD, Frauenfelder T, Strobel K. et al. Assessment of bronchial and pulmonary blood supply in non-small cell lung cancer subtypes using computed tomography perfusion. Investigative Radiology 2015; 50: 179-186
    CrossrefPubMedGoogle Scholar
  • 29 Gadaleta CD, Solbiati L, Mattioli V. et al. Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients. Radiology 2013; 267: 627-637 DOI: 10.1148/radiol.12120198.
    CrossrefPubMedGoogle Scholar
  • 30 Lewis AL, Gonzalez MV, Lloyd AW. et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. Journal of Vascular and Interventional Radiology: JVIR 2006; 17: 335-342 DOI: 10.1097/01.RVI.0000195323.46152.B3.
    CrossrefPubMedGoogle Scholar
  • 31 Kitai T, Nomura A, Miki A. et al. [Clinical benefit of bronchial arterial infusion chemotherapy to pulmonary metastasis from colorectal cancer--report of two cases]. Gan to kagaku ryoho Cancer & Chemotherapy 2003; 30: 2125-2128
    PubMedGoogle Scholar
  • 32 Kahn PC, Paul RE, Rheinlander HF. Selective bronchial arteriography and intra-arterial chemotherapy in carcinoma of the lung. Journal of Thoracic and Cardiovascular Surgery 1965; 50: 640-645
    CrossrefPubMedGoogle Scholar
  • 33 Jiang GM, Zhao JW, Chen YX. et al. [Blood supply of pulmonary metastases and its clinical significance]. Chinese Journal of Cancer 2006; 25: 885-887
    PubMedGoogle Scholar
  • 34 Sheng S, Zheng J, Cui S. et al. Complete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 gene. Anti-cancer Drugs 2015; 26: 227-231 DOI: 10.1097/cad.0000000000000167.
    CrossrefPubMedGoogle Scholar
  • 35 Kaseda S, Shimizu K, Yamane T. et al. Bronchial arterial infusion with cisplatin followed by irradiation successfully treats recurrent stage IVb thymic large cell carcinoma. European journal of Cardio-thoracic Surgery 1999; 16: 471-474
    CrossrefPubMedGoogle Scholar
  • 36 Koshiishi H, Utsumi K, Tamamoto F. et al. [Evaluation of bronchial arterial infusion (BAI) for high risk lung cancer]. Gan To Kagaku Ryoho 2000; 27: 1907-1910
    PubMedGoogle Scholar
  • 37 Freckman HA, Mendez Jr FL, Maurer ER. et al. Chemotherapy for lung cancer by intra-aortic infusion. Jama 1966; 196: 5-10
    CrossrefPubMedGoogle Scholar
  • 38 YOSHIKAWA K. Ten Yearsʼ Experience With Intra-Aortic Infusion Chemotherapy for Gastrointestinal Malignant Tumors. Japanese Journal of Clinical Oncology 1981; 11: 391-398
    PubMedGoogle Scholar
  • 39 Collins JM. Pharmacologic rationale for regional drug delivery. Journal of Clinical Oncology 1984; 2: 498-504
    CrossrefPubMedGoogle Scholar
  • 40 Takeda N, Diksic M. Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model. Journal of Neuro-oncology 1999; 41: 235-246
    CrossrefPubMedGoogle Scholar
  • 41 Vogl TJ, Lindemayr S, Naguib NN. et al. Nonselective transarterial chemoperfusion: a palliative treatment for malignant pleural mesothelioma. Radiology 2013; 266: 649-656 DOI: 10.1148/radiol.12111858.
    CrossrefPubMedGoogle Scholar
  • 42 Dempsey PJ, Ridge CA, Solomon SB. Advances in Interventional Oncology: Lung Cancer Cancer. J 2016; 22 (06) 393-400 DOI: 10.1097/PPO.0000000000000229.
    CrossrefPubMedGoogle Scholar
  • 43 Ponder E. The Coefficient of Thermal Conductivity of Blood and of Various Tissues. Journal of General Physiology 1962; 45: 545-551
    CrossrefPubMedGoogle Scholar
  • 44 Safavi AH, Mak DY, Boldt RG. et al. Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis. Lung Cancer 2021; 160: 179-186 DOI: 10.1016/j.lungcan.2021.07.007.
    CrossrefPubMedGoogle Scholar
  • 45 Hohenforst-Schmidt W, Zarogoulidis P, Stopek J. et al. DDMC-p53 gene therapy with or without cisplatin and microwave ablation. OncoTargets and Therapy 2015; 8: 1165-1173 DOI: 10.2147/ott.s83794.
    CrossrefPubMedGoogle Scholar
  • 46 Lee JM, Youk JH, Kim YK. et al. Radio-frequency thermal ablation with hypertonic saline solution injection of the lung: ex vivo and in vivo feasibility studies. European Radiology 2003; 13: 2540-2547 DOI: 10.1007/s00330-003-1876-x.
    CrossrefPubMedGoogle Scholar
  • 47 Oshima F, Yamakado K, Akeboshi M. et al. Lung radiofrequency ablation with and without bronchial occlusion: experimental study in porcine lungs. Journal of Vascular and Interventional Radiology: JVIR 2004; 15: 1451-1456 DOI: 10.1097/01.RVI.0000140640.87399.58.
    CrossrefPubMedGoogle Scholar
  • 48 Inoue Y, Miki C, Hiro J. et al. Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: A preliminary study. Oncology Reports 2005; 14: 1571-1576 DOI: 10.3892/or.14.6.1571.
    CrossrefPubMedGoogle Scholar
  • 49 Dupuy DE, DiPetrillo T, Gandhi S. et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006; 129: 738-745 DOI: 10.1378/chest.129.3.738.
    CrossrefPubMedGoogle Scholar
  • 50 Zeng Y, Yin M, Zhao Y. et al. Combination of Bronchial Arterial Infusion Chemotherapy plus Drug-Eluting Embolic Transarterial Chemoembolization for Treatment of Advanced Lung Cancer-A Retrospective Analysis of 23 Patients. J Vasc Interv Radiol 2020; 31 (10) 1645-1653 DOI: 10.1016/j.jvir.2020.06.007.
    CrossrefPubMedGoogle Scholar